The current state of diversity, equity, and inclusion in multiple sclerosis research, clinical trials, and workforce.

The article discusses the current state of diversity, equity, and inclusion in multiple sclerosis (MS) research, clinical trials, and workforce. It highlights the underrepresentation of women and non-White populations in clinical trials and research, emphasizing the need to address barriers and gaps in the MS workforce. The lack of diversity in clinical trials threatens the applicability of research findings, and addressing healthcare disparities and historical, cultural, and socioeconomic barriers to clinical trial enrollment is crucial. The article also stresses the importance of leveraging community partnerships, promoting workforce diversity, and addressing gender disparities in the neurology and MS workspace to improve the inclusivity and impact of MS research. [Extracted from the article]